Published in PLoS Negl Trop Dis on February 09, 2010
Murine schistosomiasis as a model for human schistosomiasis mansoni: similarities and discrepancies. Parasitol Res (2010) 0.91
Cysteine peptidases as schistosomiasis vaccines with inbuilt adjuvanticity. PLoS One (2014) 0.90
Screening the Schistosoma mansoni transcriptome for genes differentially expressed in the schistosomulum stage in search for vaccine candidates. Parasitol Res (2010) 0.89
On the three-finger protein domain fold and CD59-like proteins in Schistosoma mansoni. PLoS Negl Trop Dis (2013) 0.85
Computational vaccinology: an important strategy to discover new potential S. mansoni vaccine candidates. J Biomed Biotechnol (2011) 0.85
Vaccination with enzymatically cleaved GPI-anchored proteins from Schistosoma mansoni induces protection against challenge infection. Clin Dev Immunol (2012) 0.84
Identification and characterization of paramyosin from cyst wall of metacercariae implicated protective efficacy against Clonorchis sinensis infection. PLoS One (2012) 0.84
In vitro and in vivo studies for assessing the immune response and protection-inducing ability conferred by Fasciola hepatica-derived synthetic peptides containing B- and T-cell epitopes. PLoS One (2014) 0.82
Combined TLR7/8 and TLR9 ligands potentiate the activity of a Schistosoma japonicum DNA vaccine. PLoS Negl Trop Dis (2013) 0.80
Identification and characterization of six novel tetraspanins from Schistosoma japonicum. Parasit Vectors (2011) 0.80
Sm10.3, a member of the micro-exon gene 4 (MEG-4) family, induces erythrocyte agglutination in vitro and partially protects vaccinated mice against Schistosoma mansoni infection. PLoS Negl Trop Dis (2014) 0.79
Schistosome syntenin partially protects vaccinated mice against Schistosoma mansoni infection. PLoS Negl Trop Dis (2014) 0.78
Interaction Between the Neglected Tropical Disease Human Schistosomiasis and HCV Infection in Egypt: a Puzzling Relationship. J Clin Transl Hepatol (2014) 0.77
CpG oligodeoxynucleotide ligand potentiates the activity of the pVAX1-Sj26GST. Biomed Rep (2013) 0.76
DNA Vaccine Encoding the Chimeric Form of Schistosoma mansoni Sm-TSP2 and Sm29 Confers Partial Protection against Challenge Infection. PLoS One (2015) 0.76
Schistosoma mansoni tetraspanning orphan receptor (SmTOR): a new vaccine candidate against schistosomiasis. Clin Exp Immunol (2012) 0.75
Identification and immunological characterization of thioredoxin transmembrane-related protein from Clonorchis sinensis. Parasitol Res (2013) 0.75
Transcriptome analysis of the acoelomate human parasite Schistosoma mansoni. Nat Genet (2003) 2.66
Tetraspanins on the surface of Schistosoma mansoni are protective antigens against schistosomiasis. Nat Med (2006) 2.59
Identification of genes expressed in C. elegans touch receptor neurons. Nature (2002) 2.39
MEC-2 regulates C. elegans DEG/ENaC channels needed for mechanosensation. Nature (2002) 2.27
Podocin and MEC-2 bind cholesterol to regulate the activity of associated ion channels. Proc Natl Acad Sci U S A (2006) 2.16
A stomatin-domain protein essential for touch sensation in the mouse. Nature (2006) 2.08
Evolutionary and biomedical implications of a Schistosoma japonicum complementary DNA resource. Nat Genet (2003) 2.01
Flotillins and the PHB domain protein family: rafts, worms and anaesthetics. Traffic (2005) 2.01
A stomatin-like protein necessary for mechanosensation in C. elegans. Nature (1995) 2.00
The mechanosensory protein MEC-6 is a subunit of the C. elegans touch-cell degenerin channel. Nature (2002) 2.00
The SPFH domain: implicated in regulating targeted protein turnover in stomatins and other membrane-associated proteins. Trends Biochem Sci (1999) 1.97
Resistance to praziquantel: direct evidence from Schistosoma mansoni isolated from Egyptian villagers. Am J Trop Med Hyg (1999) 1.90
Immunopathology of Schistosoma mansoni infection. Clin Microbiol Rev (1989) 1.79
Making sense of the schistosome surface. Adv Parasitol (2006) 1.64
The tegument surface membranes of the human blood parasite Schistosoma mansoni: a proteomic analysis after differential extraction. Proteomics (2006) 1.63
Schistosoma mansoni tegument protein Sm29 is able to induce a Th1-type of immune response and protection against parasite infection. PLoS Negl Trop Dis (2008) 1.58
MEC-2 is recruited to the putative mechanosensory complex in C. elegans touch receptor neurons through its stomatin-like domain. Curr Biol (2004) 1.47
Schistosomiasis: from risk assessment to control. Trends Parasitol (2002) 1.44
CSS-Palm: palmitoylation site prediction with a clustering and scoring strategy (CSS). Bioinformatics (2006) 1.42
Immunity induced by the radiation-attenuated schistosome vaccine. Parasite Immunol (2005) 1.37
Identification of a novel mitochondrial complex containing mitofusin 2 and stomatin-like protein 2. J Biol Chem (2006) 1.36
Ancient origin of reggie (flotillin), reggie-like, and other lipid-raft proteins: convergent evolution of the SPFH domain. Cell Mol Life Sci (2006) 1.33
Polymyxin B as inhibitor of LPS contamination of Schistosoma mansoni recombinant proteins in human cytokine analysis. Microb Cell Fact (2007) 1.30
IgA antibodies to a protective antigen in human Schistosomiasis mansoni. J Immunol (1993) 1.30
Expression of the Necator americanus hookworm larval antigen Na-ASP-2 in Pichia pastoris and purification of the recombinant protein for use in human clinical trials. Vaccine (2005) 1.28
Identification of a stomatin orthologue in vacuoles induced in human erythrocytes by malaria parasites. A role for microbial raft proteins in apicomplexan vacuole biogenesis. J Biol Chem (2003) 1.27
Exposure to Schistosoma mansoni infection in a rural area in Brazil. II: household risk factors. Trop Med Int Health (2001) 1.24
Calpain is the target antigen of a Th1 clone that transfers protective immunity against Schistosoma mansoni. J Immunol (1996) 1.20
Stomatin-like protein 2 is overexpressed in cancer and involved in regulating cell growth and cell adhesion in human esophageal squamous cell carcinoma. Clin Cancer Res (2006) 1.19
Identification and characterization of human SLP-2, a novel homologue of stomatin (band 7.2b) present in erythrocytes and other tissues. J Biol Chem (2000) 1.18
Induction of Th1 cell-mediated protective immunity to Schistosoma mansoni by co-administration of larval antigens and IL-12 as an adjuvant. J Immunol (1996) 1.15
The radiation-attenuated vaccine against schistosomes in animal models: paradigm for a human vaccine? Adv Parasitol (1997) 1.14
Quinoline antimalarials: mechanisms of action and resistance. Int J Parasitol (1997) 1.13
In vitro cellular and humoral responses to Schistosoma mansoni vaccine candidate antigens. Acta Trop (2003) 1.12
Human antibody responses of patients living in endemic areas for schistosomiasis to the tegumental protein Sm29 identified through genomic studies. Clin Exp Immunol (2006) 1.09
Vaccination with calpain induces a Th1-biased protective immune response against Schistosoma japonicum. Infect Immun (2001) 1.09
Chemotherapeutic approaches to schistosomes: current knowledge and outlook. Parasitol Res (2002) 1.08
Unc-1: a stomatin homologue controls sensitivity to volatile anesthetics in Caenorhabditis elegans. Proc Natl Acad Sci U S A (1998) 1.06
The human immune response to defined immunogens of Schistosoma mansoni: elevated antibody levels to paramyosin in stool-negative individuals from two endemic areas in Brazil. Trans R Soc Trop Med Hyg (1990) 1.06
Defining a schistosomiasis vaccination strategy - is it really Th1 versus Th2? Parasitol Today (2000) 1.00
Exposure to Schistosoma mansoni infection in a rural area of Brazil. I: water contact. Trop Med Int Health (2001) 1.00
Antibody response of Schistosoma mansoni-infected human subjects to the recombinant P28 glutathione-S-transferase and to synthetic peptides. J Clin Microbiol (1990) 0.97
Tegument surface membranes of adult Schistosoma mansoni: development of a method for their isolation. Mol Biochem Parasitol (1983) 0.96
Identification of immunodominant Th1-type T cell epitopes from Schistosoma japonicum 28 kDa glutathione-S-transferase, a vaccine candidate. Acta Biochim Biophys Sin (Shanghai) (2005) 0.95
Combined methods for the study of water contact behavior in a rural schistosomiasis-endemic area in Brazil. Acta Trop (2005) 0.94
Prognostic significance of stomatin-like protein 2 overexpression in laryngeal squamous cell carcinoma: clinical, histologic, and immunohistochemistry analyses with tissue microarray. Hum Pathol (2007) 0.92
Modulation of T cell activation by stomatin-like protein 2. J Immunol (2008) 0.91
Cysteine 29 is the major palmitoylation site on stomatin. FEBS Lett (1999) 0.91
Saposin-like proteins are expressed in the gastrodermis of Schistosoma mansoni and are immunogenic in natural infections. Int J Infect Dis (2008) 0.89
Human IgG1 and IgG3 recognition of Schistosoma mansoni 14kDa fatty acid-binding recombinant protein. Parasite Immunol (2000) 0.87
Schistosomiasis vaccine development: approaches and prospects. Mem Inst Oswaldo Cruz (1996) 0.86
The genome of the blood fluke Schistosoma mansoni. Nature (2009) 5.94
Transcriptome analysis of the acoelomate human parasite Schistosoma mansoni. Nat Genet (2003) 2.66
Tetraspanins on the surface of Schistosoma mansoni are protective antigens against schistosomiasis. Nat Med (2006) 2.59
Chitinase and Fizz family members are a generalized feature of nematode infection with selective upregulation of Ym1 and Fizz1 by antigen-presenting cells. Infect Immun (2005) 2.51
A systematically improved high quality genome and transcriptome of the human blood fluke Schistosoma mansoni. PLoS Negl Trop Dis (2012) 2.32
A research agenda for helminth diseases of humans: the problem of helminthiases. PLoS Negl Trop Dis (2012) 2.28
Megacolon in Chagas disease: a study of inflammatory cells, enteric nerves, and glial cells. Hum Pathol (2007) 1.84
Proteins exposed at the adult schistosome surface revealed by biotinylation. Mol Cell Proteomics (2005) 1.81
The generation and utilization of a cancer-oriented representation of the human transcriptome by using expressed sequence tags. Proc Natl Acad Sci U S A (2003) 1.79
Contrasting patterns in the small-scale heterogeneity of human helminth infections in urban and rural environments in Brazil. Int J Parasitol (2006) 1.69
Synergistic associations between hookworm and other helminth species in a rural community in Brazil. Trop Med Int Health (2006) 1.61
Identification of novel proteases and immunomodulators in the secretions of schistosome cercariae that facilitate host entry. Mol Cell Proteomics (2006) 1.54
Evidence for reductive genome evolution and lateral acquisition of virulence functions in two Corynebacterium pseudotuberculosis strains. PLoS One (2011) 1.53
The Schistosoma mansoni soluble proteome: a comparison across four life-cycle stages. Mol Biochem Parasitol (2004) 1.52
Progress in the development of a recombinant vaccine for human hookworm disease: the Human Hookworm Vaccine Initiative. Int J Parasitol (2003) 1.46
Multiplex PCR assay for identification of Corynebacterium pseudotuberculosis from pure cultures and for rapid detection of this pathogen in clinical samples. J Med Microbiol (2007) 1.45
Antibodies against a secreted protein from hookworm larvae reduce the intensity of hookworm infection in humans and vaccinated laboratory animals. FASEB J (2005) 1.44
Schistosoma mansoni venom allergen-like protein 4 (SmVAL4) is a novel lipid-binding SCP/TAPS protein that lacks the prototypical CAP motifs. Acta Crystallogr D Biol Crystallogr (2014) 1.41
Age-related changes in hookworm infection, anaemia and iron deficiency in an area of high Necator americanus hookworm transmission in south-eastern Brazil. Trans R Soc Trop Med Hyg (2006) 1.40
Whole-genome analysis of Leptospira interrogans to identify potential vaccine candidates against leptospirosis. FEMS Microbiol Lett (2005) 1.34
A research agenda for helminth diseases of humans: social ecology, environmental determinants, and health systems. PLoS Negl Trop Dis (2012) 1.33
RNA interference in schistosomes: machinery and methodology. Parasitology (2009) 1.27
A research agenda for helminth diseases of humans: towards control and elimination. PLoS Negl Trop Dis (2012) 1.26
The detection limits for estimates of infection intensity in schistosomiasis mansoni established by a study in non-human primates. Int J Parasitol (2006) 1.26
Human helminth co-infection: analysis of spatial patterns and risk factors in a Brazilian community. PLoS Negl Trop Dis (2008) 1.23
Protein variation in blood-dwelling schistosome worms generated by differential splicing of micro-exon gene transcripts. Genome Res (2010) 1.22
Invasion of skin by schistosome cercariae: some neglected facts. Trends Parasitol (2003) 1.22
A comparative proteomic study of the undeveloped and developed Schistosoma mansoni egg and its contents: the miracidium, hatch fluid and secretions. Int J Parasitol (2009) 1.20
Microarray analysis identifies genes preferentially expressed in the lung schistosomulum of Schistosoma mansoni. Int J Parasitol (2005) 1.19
Glycomics analysis of Schistosoma mansoni egg and cercarial secretions. Mol Cell Proteomics (2007) 1.19
Proteomic analysis of the schistosome tegument and its surface membranes. Mem Inst Oswaldo Cruz (2006) 1.18
Multiserotype protection of mice against pneumococcal colonization of the nasopharynx and middle ear by killed nonencapsulated cells given intranasally with a nontoxic adjuvant. Infect Immun (2004) 1.18
Enzymatic shaving of the tegument surface of live schistosomes for proteomic analysis: a rational approach to select vaccine candidates. PLoS Negl Trop Dis (2011) 1.17
Proteomic analysis of secretory products from the model gastrointestinal nematode Heligmosomoides polygyrus reveals dominance of venom allergen-like (VAL) proteins. J Proteomics (2011) 1.16
Socioeconomic determinants of schistosomiasis in a poor rural area in Brazil. Acta Trop (2006) 1.15
Recognition of pneumococcal isolates by antisera raised against PspA fragments from different clades. J Med Microbiol (2008) 1.14
Increased IgG1, IFN-gamma, TNF-alpha and IL-6 responses to Mycobacterium tuberculosis antigens in patients with tuberculosis are lower after chemotherapy. Int Immunol (2010) 1.12
Regulatory T cells phenotype in different clinical forms of Chagas' disease. PLoS Negl Trop Dis (2011) 1.10
Immunity to schistosomiasis: glycans are potential antigenic targets for immune intervention. Exp Parasitol (2003) 1.10
Saci-1, -2, and -3 and Perere, four novel retrotransposons with high transcriptional activities from the human parasite Schistosoma mansoni. J Virol (2004) 1.09
Immune effector mechanisms against schistosomiasis: looking for a chink in the parasite's armour. Trends Parasitol (2009) 1.09
Behavioral disorders and low quality of life in children and adolescents with chronic kidney disease. Pediatr Nephrol (2010) 1.08
Elimination of Schistosoma mansoni Adult Worms by Rhesus Macaques: Basis for a Therapeutic Vaccine? PLoS Negl Trop Dis (2008) 1.08
Type 1 chemokine receptor expression in Chagas' disease correlates with morbidity in cardiac patients. Infect Immun (2005) 1.07
IL-10 is crucial for the transition from acute to chronic disease state during infection of mice with Schistosoma mansoni. Eur J Immunol (2003) 1.07
Gene expression patterns in larval Schistosoma mansoni associated with infection of the mammalian host. PLoS Negl Trop Dis (2011) 1.07
Immunization of mice with single PspA fragments induces antibodies capable of mediating complement deposition on different pneumococcal strains and cross-protection. Clin Vaccine Immunol (2010) 1.06
Generalized urticaria induced by the Na-ASP-2 hookworm vaccine: implications for the development of vaccines against helminths. J Allergy Clin Immunol (2012) 1.05
Schistosoma mansoni: In vitro schistosomicidal activity of piplartine. Exp Parasitol (2010) 1.04
Insights into blood feeding by schistosomes from a proteomic analysis of worm vomitus. Mol Biochem Parasitol (2011) 1.03
Monokine induced by interferon gamma and IFN-gamma response to a fusion protein of Mycobacterium tuberculosis ESAT-6 and CFP-10 in Brazilian tuberculosis patients. Microbes Infect (2005) 1.03
Schistosomiasis--a century searching for chemotherapeutic drugs. Parasitol Res (2006) 1.03
No overt cellular inflammation around intravascular schistosomes in vivo. J Parasitol (2006) 1.01
Bordetella pertussis monophosphoryl lipid A as adjuvant for inactivated split virion influenza vaccine in mice. Vaccine (2009) 1.00
Potential role of CD4+CD25HIGH regulatory T cells in morbidity in Chagas disease. Front Biosci (2007) 1.00
Short report: quantification of leishmaniavirus RNA in clinical samples and its possible role in pathogenesis. Am J Trop Med Hyg (2003) 1.00
Parameters of the attenuated schistosome vaccine evaluated in the olive baboon. Infect Immun (2004) 0.99
Exposure to Schistosoma mansoni infection in a rural area in Brazil. Part III: household aggregation of water-contact behaviour. Trop Med Int Health (2004) 0.97
A combined approach for comparative exoproteome analysis of Corynebacterium pseudotuberculosis. BMC Microbiol (2011) 0.97
From genomes to vaccines via the proteome. Mem Inst Oswaldo Cruz (2004) 0.97
A quantitative view of the transcriptome of Schistosoma mansoni adult-worms using SAGE. BMC Genomics (2007) 0.97
Relevance of long-lived CD8(+) T effector memory cells for protective immunity elicited by heterologous prime-boost vaccination. Front Immunol (2012) 0.96
Putative ATP-binding cassette transporter is essential for Brucella ovis pathogenesis in mice. Infect Immun (2011) 0.96
Chemokine receptor expression on the surface of peripheral blood mononuclear cells in Chagas disease. J Infect Dis (2004) 0.96
A multihousehold study reveals a positive correlation between age, severity of ocular toxoplasmosis, and levels of glycoinositolphospholipid-specific immunoglobulin A. J Infect Dis (2004) 0.96
Profile of central and effector memory T cells in the progression of chronic human chagas disease. PLoS Negl Trop Dis (2009) 0.96
Human helminth co-infection: no evidence of common genetic control of hookworm and Schistosoma mansoni infection intensity in a Brazilian community. Int J Parasitol (2009) 0.95
Health education through analogies: preparation of a community for clinical trials of a vaccine against hookworm in an endemic area of Brazil. PLoS Negl Trop Dis (2010) 0.95
Schistosome vaccines: a critical appraisal. Mem Inst Oswaldo Cruz (2006) 0.95
Differential impact of metacyclic and blood trypomastigotes on parasitological, serological and phenotypic features triggered during acute Trypanosoma cruzi infection in dogs. Acta Trop (2007) 0.94
Induction of immunogenicity by live attenuated Leishmania donovani centrin deleted parasites in dogs. Vaccine (2013) 0.94
The role of population movement in the epidemiology and control of schistosomiasis in Brazil: a preliminary typology of population movement. Mem Inst Oswaldo Cruz (2010) 0.94
Nasal immunization of mice with Lactobacillus casei expressing the Pneumococcal Surface Protein A: induction of antibodies, complement deposition and partial protection against Streptococcus pneumoniae challenge. Microbes Infect (2008) 0.94
Expression of Streptococcus pneumoniae antigens, PsaA (pneumococcal surface antigen A) and PspA (pneumococcal surface protein A) by Lactobacillus casei. FEMS Microbiol Lett (2003) 0.94
Research priorities for neglected infectious diseases in Latin America and the Caribbean region. PLoS Negl Trop Dis (2010) 0.94
Analysis of serum cross-reactivity and cross-protection elicited by immunization with DNA vaccines against Streptococcus pneumoniae expressing PspA fragments from different clades. Infect Immun (2002) 0.94
The schistosome oesophageal gland: initiator of blood processing. PLoS Negl Trop Dis (2013) 0.93
Optimized immune response elicited by a DNA vaccine expressing pneumococcal surface protein a is characterized by a balanced immunoglobulin G1 (IgG1)/IgG2a ratio and proinflammatory cytokine production. Clin Vaccine Immunol (2008) 0.93
Induction of CD4(+)CD25(+)FOXP3(+) regulatory T cells during human hookworm infection modulates antigen-mediated lymphocyte proliferation. PLoS Negl Trop Dis (2011) 0.93
Human schistosomiasis mansoni: intensity of infection differentially affects the production of interleukin-10, interferon-gamma and interleukin-13 by soluble egg antigen or adult worm antigen stimulated cultures. Trans R Soc Trop Med Hyg (2004) 0.93
Candidate gene analysis of ocular toxoplasmosis in Brazil: evidence for a role for toll-like receptor 9 (TLR9). Mem Inst Oswaldo Cruz (2009) 0.93
Association of a NOD2 gene polymorphism and T-helper 17 cells with presumed ocular toxoplasmosis. J Infect Dis (2012) 0.93
Tissue expression patterns of Schistosoma mansoni Venom Allergen-Like proteins 6 and 7. Int J Parasitol (2012) 0.92
Schistosome transcriptome: insights and perspectives for functional genomics. Trends Parasitol (2004) 0.92
Plasma concentrations and role of macrophage inflammatory protein-1alpha during chronic Schistosoma mansoni infection in humans. J Infect Dis (2002) 0.91
A potent trypanocidal component from the fungus Lentinus strigosus inhibits trypanothione reductase and modulates PBMC proliferation. Mem Inst Oswaldo Cruz (2008) 0.91
Co-administration of plasmid expressing IL-12 with 14-kDa Schistosoma mansoni fatty acid-binding protein cDNA alters immune response profiles and fails to enhance protection induced by Sm14 DNA vaccine alone. Microbes Infect (2006) 0.91
Necator americanus and helminth co-infections: further down-modulation of hookworm-specific type 1 immune responses. PLoS Negl Trop Dis (2011) 0.90